The efficacy of reboxetine in the treatm
✍
P. N. Dannon; I. Iancu; L. Grunhaus
📂
Article
📅
2002
🏛
John Wiley and Sons
🌐
English
⚖ 57 KB
👁 2 views
## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the first‐line treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi